{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T22:14:52Z","timestamp":1772057692998,"version":"3.50.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MUST-MGH Collaborative","award":["MUST\/FOM\/23\/3"],"award-info":[{"award-number":["MUST\/FOM\/23\/3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Coronavirus disease (COVID-19) vaccine hesitancy is a global challenge. In low-\u00a0and\u00a0middle-income countries (LMICs), the problem has persisted despite vaccine availability and decreasing infections. In Uganda, there is still limited information on the extent and predictors of vaccine hesitancy. This study sought to assess the prevalence and predictors of COVID-19 vaccine hesitancy, and the effectiveness of an intervention that involved community pharmacy counseling in combating COVID-19 vaccine hesitancy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 394 participants were enrolled in a 4-week prospective cohort interventional study. The study was conducted across eight community pharmacies in Mbarara City, between 9:00 AM and 5:00 PM daily. The study personnel ascertained the vaccination status of all clients seeking community pharmacy services. All unvaccinated clients were consecutively assessed for eligibility, and eligible clients were systematically enrolled after receiving the community pharmacy services for which they requested. The study intervention involved structured participant counseling (within the pharmacy premise), follow-up short message service (weekly), and telephone calls (bi-weekly). Only participants who did not accept to receive the COVID-19 vaccine despite counseling were followed up for four weeks, or until they accepted to receive a COVID-19 vaccine. The effectiveness of the community pharmacy counseling intervention was determined as an increase in COVID-19 vaccine acceptance, and desirable attitudinal change towards COVID-19 disease, vaccination exercise, and vaccines. Descriptive analysis was used to summarize data, and multivariate analysis was used to determine the predictors of COVID-19 vaccine hesitancy. A <jats:italic>p<\/jats:italic>-value &lt; 0.05 was considered statistically significant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of 394 participants, 221 (56%) were hesitant to receive a COVID-19 vaccine. Participants expressed several reasons (mean 2\u00b11) for COVID-19 vaccine hesitancy, mostly concerning vaccine safety (<jats:italic>N<\/jats:italic>=160, 47.3%). The overall COVID-19 vaccine acceptance rate increased by 25.4 percent points (43.9 \u2013 69.3 percent points) after the study intervention. Age, religion, level of education, distance from the nearest public health facility, having a friend\/family diagnosed with COVID-19, and personal suspicion of contracting COVID-19 were significant predictors of COVID-19 vaccine hesitancy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>COVID-19 vaccine hesitancy is a big challenge in Uganda. A mix of sociodemographic and COVID-19 vaccine perceptions are the key predictors of COVID-19 vaccine hesitancy. Although COVID-19 vaccines were not available at the time of the study, this study found that structured counseling interventions can improve COVID-19 vaccine acceptance rates. Larger prospective studies should evaluate the effectiveness of similar interventions in community pharmacies and other healthcare settings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-023-17532-4","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T18:01:28Z","timestamp":1704564088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["COVID-19 vaccine hesitancy: assessing the prevalence, predictors, and effectiveness of a community pharmacy based counseling intervention"],"prefix":"10.1186","volume":"24","author":[{"given":"Joshua","family":"Kiptoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Isiiko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadele Mekuriya","family":"Yadesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tumugumye","family":"Rhodah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.","family":"Alele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar Mugema","family":"Mulogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,6]]},"reference":[{"issue":"10229","key":"17532_CR1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0140-6736(20)30553-5","volume":"395","author":"N Kandel","year":"2020","unstructured":"Kandel N, Chungong S, Omaar A, Xing J. Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries. Lancet. 2020;395(10229):1047\u201353.","journal-title":"Lancet"},{"issue":"12","key":"17532_CR2","doi-asserted-by":"publisher","first-page":"e007179","DOI":"10.1136\/bmjgh-2021-007179","volume":"6","author":"GA Tessema","year":"2021","unstructured":"Tessema GA, Kinfu Y, Dachew BA, Tesema AG, Assefa Y, Alene KA, et al. The COVID-19 pandemic and healthcare systems in Africa: a scoping review of preparedness, impact and response. BMJ Global Health. 2021;6(12):e007179.","journal-title":"BMJ Global Health"},{"issue":"5","key":"17532_CR3","doi-asserted-by":"publisher","first-page":"e008477","DOI":"10.1136\/bmjgh-2022-008477","volume":"7","author":"AT Levin","year":"2022","unstructured":"Levin AT, Owusu-Boaitey N, Pugh S, Fosdick BK, Zwi AB, Malani A, et al. Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications. BMJ Global Health. 2022;7(5):e008477.","journal-title":"BMJ Global Health"},{"issue":"3","key":"17532_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jtm\/taaa037","volume":"27","author":"H Lau","year":"2020","unstructured":"Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Schubert J, Bania J, et al. The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China. J Travel Med. 2020;27(3):1\u20137.","journal-title":"J Travel Med."},{"key":"17532_CR5","doi-asserted-by":"publisher","unstructured":"Farooq F, Khan J, Khan MUG. Effect of Lockdown on the spread of COVID-19 in Pakistan. arXiv preprint arXiv:200509422. 2020;1\u20137. Available from: https:\/\/doi.org\/10.48550\/arXiv.2005.09422.","DOI":"10.48550\/arXiv.2005.09422"},{"issue":"4","key":"17532_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.dsx.2020.05.026","volume":"14","author":"S Ghosal","year":"2020","unstructured":"Ghosal S, Bhattacharyya R, Majumder M. Impact of complete lockdown on total infection and death rates: a hierarchical cluster analysis. Diabetes Metab Syndr. 2020;14(4):707\u201311.","journal-title":"Diabetes Metab Syndr"},{"key":"17532_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12063-021-00179-y","volume":"15","author":"Z Yu","year":"2021","unstructured":"Yu Z, Razzaq A, Rehman A, Shah A, Jameel K, Mor RS. Disruption in global supply chain and socio-economic shocks: a lesson from COVID-19 for sustainable production and consumption. Oper Manag Res. 2021;15:233\u201348.","journal-title":"Oper Manag Res."},{"issue":"4","key":"17532_CR8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s10900-021-00961-w","volume":"46","author":"JK Matovu","year":"2021","unstructured":"Matovu JK, Kabwama SN, Ssekamatte T, Ssenkusu J, Wanyenze RK. COVID-19 awareness, adoption of COVID-19 preventive measures, and effects of COVID-19 lockdown among adolescent boys and young men in Kampala Uganda. J Community Health. 2021;46(4):842\u201353.","journal-title":"J Community Health"},{"key":"17532_CR9","doi-asserted-by":"publisher","first-page":"105199","DOI":"10.1016\/j.worlddev.2020.105199","volume":"137","author":"MK Kansiime","year":"2021","unstructured":"Kansiime MK, Tambo JA, Mugambi I, Bundi M, Kara A, Owuor C. COVID-19 implications on household income and food security in Kenya and Uganda: Findings from a rapid assessment. World Dev. 2021;137:105199.","journal-title":"World Dev"},{"key":"17532_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jad.2021.09.052","volume":"296","author":"C Cao","year":"2022","unstructured":"Cao C, Wang L, Fang R, Liu P, Bi Y, Luo S, et al. Anxiety, depression, and PTSD symptoms among high school students in china in response to the COVID-19 pandemic and lockdown. J Affect Disord. 2022;296:126\u20139.","journal-title":"J Affect Disord"},{"issue":"3","key":"17532_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/vaccines10030386","volume":"10","author":"E Batteux","year":"2022","unstructured":"Batteux E, Mills F, Jones LF, Symons C, Weston D. The Effectiveness of Interventions for Increasing COVID-19 Vaccine Uptake: A Systematic Review. Vaccines. 2022;10(3):386.","journal-title":"Vaccines"},{"key":"17532_CR12","unstructured":"Derevyankina E, Yankovskaya D. The impact of Covid-19 on supply chain management and global economy development. 2021;9(4):765\u201374."},{"key":"17532_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/PPA.S293647","volume":"15","author":"A Bante","year":"2021","unstructured":"Bante A, Mersha A, Tesfaye A, Tsegaye B, Shibiru S, Ayele G, et al. Adherence with COVID-19 preventive measures and associated factors among residents of Dirashe District Southern Ethiopia. Patient Prefer Adher. 2021;15:237\u201349.","journal-title":"Patient Prefer Adher"},{"key":"17532_CR14","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1017\/dmp.2021.255","volume":"17","author":"PA Gandhi","year":"2023","unstructured":"Gandhi PA, Rehman T, Ilanchoorian D, Kathirvel S. Community Preparedness and Practices for Prevention and Control of COVID-19 (COP-COVID): An Assessment from Rural Northern India. Disaster Med Public Health Prepared. 2023;17:e29.","journal-title":"Disaster Med Public Health Prepared"},{"key":"17532_CR15","first-page":"3751","volume":"2020","author":"T Tadesse","year":"2019","unstructured":"Tadesse T, Alemu T, Amogne G, Endazenaw G, Mamo E, Predictors of coronavirus disease,. (COVID-19) prevention practices using health belief model among employees in Addis Ababa, Ethiopia, 2020. Infect Drug Resist. 2019;2020:3751\u201361.","journal-title":"Infect Drug Resist"},{"key":"17532_CR16","doi-asserted-by":"publisher","first-page":"03086","DOI":"10.7189\/jogh.11.03086","volume":"11","author":"M Tatar","year":"2021","unstructured":"Tatar M, Shoorekchali JM, Faraji MR, Wilson FA. International COVID-19 vaccine inequality amid the pandemic: Perpetuating a global crisis? J Global Health. 2021;11:03086.","journal-title":"J Global Health."},{"issue":"4","key":"17532_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/14760584.2022.2014819","volume":"21","author":"E Altindis","year":"2022","unstructured":"Altindis E. Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic. Expert Rev Vaccines. 2022;21(4):427\u201330.","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"17532_CR18","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/S1473-3099(21)00344-3","volume":"21","author":"T Burki","year":"2021","unstructured":"Burki T. Global COVID-19 vaccine inequity. Lancet Infect Dis. 2021;21(7):922\u20133.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"17532_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/diseases11010032","volume":"11","author":"EA Ochola","year":"2023","unstructured":"Ochola EA. Vaccine hesitancy in Sub-Saharan Africa in the Context of COVID-19 vaccination exercise: a systematic review. Diseases. 2023;11(1):32.","journal-title":"Diseases"},{"issue":"2","key":"17532_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/vaccines9020160","volume":"9","author":"M Sallam","year":"2021","unstructured":"Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):160.","journal-title":"Vaccines"},{"key":"17532_CR21","volume-title":"Ten health issues WHO will tackle this year","author":"WHO. World Health Organization","year":"2019","unstructured":"WHO. World Health Organization. Ten health issues WHO will tackle this year. 2019."},{"issue":"2","key":"17532_CR22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/1468-0009.12503","volume":"99","author":"M Eccleston-Turner","year":"2021","unstructured":"Eccleston-Turner M, Upton H. International collaboration to ensure equitable access to vaccines for COVID-19: the ACT-Accelerator and the COVAX facility. The Milbank Quarterly. 2021;99(2):426\u201349.","journal-title":"The Milbank Quarterly."},{"key":"17532_CR23","volume-title":"Accelerating COVID-19 Vaccine Deployment","author":"WHO","year":"2022","unstructured":"WHO. Accelerating COVID-19 Vaccine Deployment. 2022."},{"issue":"2","key":"17532_CR24","first-page":"203","volume":"43","author":"RS Wong","year":"2021","unstructured":"Wong RS. COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects. Malays J Pathol. 2021;43(2):203\u201317.","journal-title":"Malays J Pathol"},{"issue":"19","key":"17532_CR25","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.vaccine.2014.01.081","volume":"32","author":"HJ Larson","year":"2014","unstructured":"Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007\u20132012. Vaccine. 2014;32(19):2150\u20139.","journal-title":"Vaccine"},{"key":"17532_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fpubh.2015.00269","volume":"3","author":"I Hajj Hussein","year":"2015","unstructured":"Hajj Hussein I, Chams N, Chams S, El Sayegh S, Badran R, Raad M, et al. Vaccines through centuries: major cornerstones of global health. Front Public Health. 2015;3:269.","journal-title":"Front Public Health"},{"issue":"1","key":"17532_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/SLA.0000000000005176","volume":"275","author":"NK Prasad","year":"2022","unstructured":"Prasad NK, Lake R, Englum BR, Turner DJ, Siddiqui T, Mayorga-Carlin M, et al. COVID-19 vaccination associated with reduced postoperative SARS-CoV-2 infection and morbidity. Ann Surg. 2022;275(1):31.","journal-title":"Ann Surg"},{"key":"17532_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejca.2022.04.036","volume":"171","author":"DJ Pinato","year":"2022","unstructured":"Pinato DJ, Ferrante D, Aguilar-Company J, Bower M, Salazar R, Mirallas O, et al. Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer. Eur J Cancer. 2022;171:64\u201374.","journal-title":"Eur J Cancer"},{"key":"17532_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2020.12.011","volume":"170","author":"JY Chung","year":"2021","unstructured":"Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: The status and perspectives in delivery points of view. Adv Drug Deliv Rev. 2021;170:1\u201325.","journal-title":"Adv Drug Deliv Rev"},{"issue":"16","key":"17532_CR30","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2217\/cer-2022-0069","volume":"11","author":"MW Reynolds","year":"2022","unstructured":"Reynolds MW, Secora A, Joules A, Albert L, Brinkley E, Kwon T, et al. Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case\u2013control design. J Comp Eff Res. 2022;11(16):1161\u201372.","journal-title":"J Comp Eff Res"},{"key":"17532_CR31","first-page":"1","volume":"9","author":"M Liu","year":"2022","unstructured":"Liu M, Li Y. Advances in COVID-19 vaccines and new coronavirus variants. Front Med. 2022;9:1\u201310.","journal-title":"Front Med."},{"issue":"8","key":"17532_CR32","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3390\/vaccines10081356","volume":"10","author":"JK Fajar","year":"2022","unstructured":"Fajar JK, Sallam M, Soegiarto G, Sugiri YJ, Anshory M, Wulandari L, et al. Global Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysis. Vaccines. 2022;10(8):1356.","journal-title":"Vaccines"},{"issue":"6","key":"17532_CR33","doi-asserted-by":"publisher","first-page":"e057322","DOI":"10.1136\/bmjopen-2021-057322","volume":"12","author":"ST Wafula","year":"2022","unstructured":"Wafula ST, Mugume IB, Sensasi B, Okware S, Chimbaru A, Nanyunja M, et al. Intention to vaccinate against COVID-19 and adherence to non-pharmaceutical interventions against COVID-19 prior to the second wave of the pandemic in Uganda: a cross-sectional study. BMJ Open. 2022;12(6):e057322.","journal-title":"BMJ Open"},{"key":"17532_CR34","volume-title":"Vaccines Approved for Use in Uganda","author":"CV Tracker","year":"2022","unstructured":"Tracker CV. Vaccines Approved for Use in Uganda. 2022. Available from: https:\/\/covid19.trackvaccines.org\/country\/uganda\/ ."},{"key":"17532_CR35","volume-title":"Ministry of Health, Republic of Uganda: Update on COVID-19 vaccination in Uganda","author":"MoH","year":"2022","unstructured":"MoH. Ministry of Health, Republic of Uganda: Update on COVID-19 vaccination in Uganda. 2022. Cited 2022 25th June. Available from: https:\/\/www.health.go.ug\/covid\/ ."},{"key":"17532_CR36","unstructured":"Data OWi. Coronavirus (COVID-19) Vaccinations 2023. Cited 2023 7th March. Available from: https:\/\/ourworldindata.org\/covid-vaccinations."},{"issue":"3","key":"17532_CR37","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/vaccines9030256","volume":"9","author":"P Plans-Rubi\u00f3","year":"2021","unstructured":"Plans-Rubi\u00f3 P. Vaccination coverage for routine vaccines and herd immunity levels against measles and pertussis in the world in 2019. Vaccines. 2021;9(3):256.","journal-title":"Vaccines"},{"key":"17532_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11604\/pamj.2021.38.3.27401","volume":"38","author":"AA Afolabi","year":"2021","unstructured":"Afolabi AA, Ilesanmi OS. Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context. Pan Afr Med J. 2021;38:1\u20137.","journal-title":"Pan Afr Med J."},{"issue":"8","key":"17532_CR39","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3390\/vaccines9080814","volume":"9","author":"T Acheampong","year":"2021","unstructured":"Acheampong T, Akorsikumah EA, Osae-Kwapong J, Khalid M, Appiah A, Amuasi JH. Examining vaccine Hesitancy in Sub-Saharan Africa: a survey of the knowledge and attitudes among adults to receive COVID-19 vaccines in Ghana. Vaccines. 2021;9(8):814.","journal-title":"Vaccines"},{"issue":"9","key":"17532_CR40","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3390\/vaccines10091401","volume":"10","author":"JN Dinga","year":"2022","unstructured":"Dinga JN, Njoh AA, Gamua SD, Muki SE, Titanji VP. Factors driving COVID-19 Vaccine hesitancy in Cameroon and their implications for Africa: A comparison of two cross-sectional studies conducted 19 months apart in 2020 and 2022. Vaccines. 2022;10(9):1401.","journal-title":"Vaccines"},{"key":"17532_CR41","doi-asserted-by":"crossref","unstructured":"Ouni PD, Namulondo R, Wanume B, Okia D, Olupot PO, Nantale R, et al. COVID-19 vaccine hesitancy among health workers in rural Uganda: A mixed methods study. Vaccine: X. 2023;13:100260.","DOI":"10.1016\/j.jvacx.2023.100260"},{"issue":"1","key":"17532_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41256-022-00255-1","volume":"7","author":"BB Ackah","year":"2022","unstructured":"Ackah BB, Woo M, Stallwood L, Fazal ZA, Okpani A, Ukah UV, et al. COVID-19 vaccine hesitancy in Africa: a scoping review. Global Health Res Policy. 2022;7(1):1\u201320.","journal-title":"Global Health Res Policy"},{"key":"17532_CR43","first-page":"204993612110243","volume":"8","author":"F Bongomin","year":"2021","unstructured":"Bongomin F, Olum R, Andia-Biraro I, Nakwagala FN, Hassan KH, Nassozi DR, et al. COVID-19 vaccine acceptance among high-risk populations in Uganda. Ther Adv Infect Dis. 2021;8:20499361211024376.","journal-title":"Ther Adv Infect Dis"},{"issue":"1","key":"17532_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ijmm.2020.4596","volume":"46","author":"D Calina","year":"2020","unstructured":"Calina D, Docea AO, Petrakis D, Egorov AM, Ishmukhametov AA, Gabibov AG, et al. Towards effective COVID-19 vaccines: updates, perspectives and challenges (Review). Int J Mol Med. 2020;46(1):3\u201316.","journal-title":"Int J Mol Med"},{"issue":"6","key":"17532_CR45","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/vaccines9060593","volume":"9","author":"W Jennings","year":"2021","unstructured":"Jennings W, Stoker G, Bunting H, Valgar\u00f0sson VO, Gaskell J, Devine D, et al. Lack of trust, conspiracy beliefs, and social media use predict COVID-19 vaccine hesitancy. Vaccines. 2021;9(6):593.","journal-title":"Vaccines"},{"issue":"1","key":"17532_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12992-021-00668-6","volume":"17","author":"B Bright","year":"2021","unstructured":"Bright B, Babalola CP, Sam-Agudu NA, Onyeaghala AA, Olatunji A, Aduh U, et al. COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa. Glob Health. 2021;17(1):24.","journal-title":"Glob Health"},{"issue":"2","key":"17532_CR47","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3390\/ijerph18020744","volume":"18","author":"JE Marco-Franco","year":"2021","unstructured":"Marco-Franco JE, Pita-Barros P, Vivas-Orts D, Gonz\u00e1lez-de-Juli\u00e1n S, Vivas-Consuelo D. COVID-19, fake news, and vaccines: should regulation be implemented? Int J Environ Res Public Health. 2021;18(2):744.","journal-title":"Int J Environ Res Public Health"},{"key":"17532_CR48","unstructured":"Forbes. 2021. Cited 2023 21st March. Available from: https:\/\/www.forbes.com\/sites\/jemimamcevoy\/2021\/06\/03\/microchips-and-shedding-here-are-5-debunked-covid-vaccine-conspiracy-theories-spreading-online\/."},{"key":"17532_CR49","volume-title":"Strategic Advisory Group of Experts on Immunization (SAGE)","author":"WHO","year":"2022","unstructured":"WHO. Strategic Advisory Group of Experts on Immunization (SAGE). 2022."},{"key":"17532_CR50","doi-asserted-by":"crossref","unstructured":"Nawas GT, Zeidan RS, Edwards CA, El-Desoky RH. Barriers to COVID-19 Vaccines and Strategies to Improve Acceptability and Uptake. J Pharm Pract. 2022;36(4):08971900221081621.","DOI":"10.1177\/08971900221081621"},{"issue":"7876","key":"17532_CR51","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41586-021-03843-2","volume":"597","author":"H Dai","year":"2021","unstructured":"Dai H, Saccardo S, Han MA, Roh L, Raja N, Vangala S, et al. Behavioural nudges increase COVID-19 vaccinations. Nature. 2021;597(7876):404\u20139.","journal-title":"Nature"},{"key":"17532_CR52","unstructured":"Licensed drug outlets in Mbarara city. 2021. Cited 24th October 2021. Available from: https:\/\/www.nda.or.ug\/licensed-outlets\/."},{"key":"17532_CR53","unstructured":"Bertram D. (n.d.). Likert scales. 2007;2(10):1-10.  Cited 30th March 2023. Retrieved from  http:\/\/poincare.matf.bg.ac.rs\/~kristina\/topicdane-likert.pdf.\u00a0"},{"issue":"12","key":"17532_CR54","doi-asserted-by":"publisher","first-page":"e0261125","DOI":"10.1371\/journal.pone.0261125","volume":"16","author":"R Mohammed","year":"2021","unstructured":"Mohammed R, Nguse TM, Habte BM, Fentie AM, Gebretekle GB. COVID-19 vaccine hesitancy among Ethiopian healthcare workers. PloS One. 2021;16(12):e0261125.","journal-title":"PloS One"},{"issue":"1","key":"17532_CR55","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1186\/s12913-021-07037-4","volume":"21","author":"KGM Danabal","year":"2021","unstructured":"Danabal KGM, Magesh SS, Saravanan S, Gopichandran V. Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India \u2013 a community based survey. BMC Health Serv Res. 2021;21(1):994.","journal-title":"BMC Health Serv Res"},{"issue":"9","key":"17532_CR56","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/vaccines10091373","volume":"10","author":"N Bain","year":"2022","unstructured":"Bain N, Nguyen M, Grech L, Day D, McCartney A, Webber K, et al. COVID-19 vaccine hesitancy in Australian patients with solid organ cancers. Vaccines. 2022;10(9):1373.","journal-title":"Vaccines"},{"issue":"11","key":"17532_CR57","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1016\/j.numecd.2021.09.002","volume":"31","author":"D Scoccimarro","year":"2021","unstructured":"Scoccimarro D, Panichi L, Ragghianti B, Silverii A, Mannucci E, Monami M. Sars-CoV2 vaccine hesitancy in Italy: a survey on subjects with diabetes. Nutr Metab Cardiovasc Dis. 2021;31(11):3243\u20136.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"17532_CR58","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1017\/dmp.2021.311","volume":"16","author":"AA Asadi-Pooya","year":"2022","unstructured":"Asadi-Pooya AA, Barzegar Z, Sadeghian S, Nezafat A, Shahisavandi M, Nabavizadeh SA. COVID-19 vaccine hesitancy among patients with epilepsy or other chronic conditions. Disast Med Public Health Prepared. 2022;16(5):1848\u201350.","journal-title":"Disast Med Public Health Prepared"},{"issue":"51","key":"17532_CR59","doi-asserted-by":"publisher","first-page":"8090","DOI":"10.1016\/j.vaccine.2020.11.013","volume":"38","author":"O Sarasty","year":"2020","unstructured":"Sarasty O, Carpio CE, Hudson D, Guerrero-Ochoa PA, Borja I. The demand for a COVID-19 vaccine in Ecuador. Vaccine. 2020;38(51):8090\u20138.","journal-title":"Vaccine"},{"issue":"9","key":"17532_CR60","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1080\/21645515.2020.1790279","volume":"16","author":"LP Wong","year":"2020","unstructured":"Wong LP, Alias H, Wong P-F, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vacc Immunother. 2020;16(9):2204\u201314.","journal-title":"Hum Vacc Immunother"},{"issue":"2","key":"17532_CR61","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.vaccine.2021.11.023","volume":"40","author":"L Cambon","year":"2022","unstructured":"Cambon L, Schwarzinger M, Alla F. Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: a challenge for one of the world\u2019s most vaccine-hesitant countries. Vaccine. 2022;40(2):178\u201382.","journal-title":"Vaccine"},{"issue":"12","key":"17532_CR62","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1080\/21645515.2021.2000817","volume":"17","author":"A Ye\u015filtepe","year":"2021","unstructured":"Ye\u015filtepe A, Aslan S, Bulbuloglu S. Investigation of perceived fear of COVID-19 and vaccine hesitancy in nursing students. Hum Vacc Immunother. 2021;17(12):5030\u20137.","journal-title":"Hum Vacc Immunother"},{"key":"17532_CR63","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2147\/RMHP.S368057","volume":"15","author":"DE Yehualashet","year":"2022","unstructured":"Yehualashet DE, Seboka BT, Tesfa GA, Mamo TT, Yawo MN, Hailegebreal S. Prevalence and determinants of COVID-19 vaccine hesitancy among the Ethiopian population: a systematic review. Risk Manag Healthc Policy. 2022;15:1433\u201345.","journal-title":"Risk Manag Healthc Policy."},{"issue":"3","key":"17532_CR64","doi-asserted-by":"publisher","first-page":"794","DOI":"10.4269\/ajtmh.20-1506","volume":"104","author":"DE Lucero-Prisno","year":"2021","unstructured":"Lucero-Prisno DE, Ogunkola IO, Imo UF, Adebisi YA. Who Will Pay for the COVID-19 Vaccines for Africa? Am J Trop Med Hyg. 2021;104(3):794\u20136.","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"17532_CR65","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/vaccines9111275","volume":"9","author":"A Zaidi","year":"2021","unstructured":"Zaidi A, Elmasaad A, Alobaidli H, Sayed R, Al-Ali D, Al-Kuwari D, et al. Attitudes and Intentions toward COVID-19 vaccination among Health professions students and faculty in Qatar. Vaccines. 2021;9(11):1275.","journal-title":"Vaccines"},{"issue":"5","key":"17532_CR66","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/vaccines10050671","volume":"10","author":"E Savoia","year":"2022","unstructured":"Savoia E, Harriman NW, Piltch-Loeb R, Bonetti M, Toffolutti V, Testa MA. Exploring the association between misinformation endorsement, opinions on the government response, risk perception, and COVID-19 vaccine hesitancy in the US, Canada, and Italy. Vaccines. 2022;10(5):671.","journal-title":"Vaccines"},{"key":"17532_CR67","doi-asserted-by":"crossref","unstructured":"Kobayashi T, Nishina Y, Tomoi H, Harada K, Matsumoto E, Inaba K, et al. 439. Corowa-kun: Impact of a COVID-19 Vaccine Information Chatbot on Vaccine Hesitancy, Japan 2021. Open Forum Infect Dis. 2021;8(Supplement_1):S321-S2.","DOI":"10.1093\/ofid\/ofab466.638"},{"issue":"12","key":"17532_CR68","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1080\/10410236.2022.2035943","volume":"37","author":"BR Bates","year":"2022","unstructured":"Bates BR, Villegas-Botero A, Costales JA, Moncayo AL, Tami A, Carvajal A, et al. COVID-19 vaccine hesitancy in three Latin American countries: reasons given for not becoming vaccinated in Colombia, Ecuador, and Venezuela. Health Commun. 2022;37(12):1465\u201375.","journal-title":"Health Commun"},{"key":"17532_CR69","doi-asserted-by":"publisher","first-page":"215013272110407","DOI":"10.1177\/21501327211040746","volume":"12","author":"PA McElfish","year":"2021","unstructured":"McElfish PA, Willis DE, Shah SK, Bryant-Moore K, Rojo MO, Selig JP. Sociodemographic determinants of COVID-19 vaccine hesitancy, fear of infection, and protection self-efficacy. J Prim Care Commun Health. 2021;12:21501327211040744.","journal-title":"J Prim Care Commun Health"},{"issue":"1","key":"17532_CR70","doi-asserted-by":"publisher","first-page":"2013694","DOI":"10.1080\/21645515.2021.2013694","volume":"18","author":"H Ouyang","year":"2022","unstructured":"Ouyang H, Ma X, Wu X. The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic. Hum Vacc Immunother. 2022;18(1):2013694.","journal-title":"Hum Vacc Immunother"},{"issue":"3","key":"17532_CR71","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/vaccines9030300","volume":"9","author":"P Soares","year":"2021","unstructured":"Soares P, Rocha JV, Moniz M, Gama A, Laires PA, Pedro AR, et al. Factors associated with COVID-19 vaccine hesitancy. Vaccines. 2021;9(3):300.","journal-title":"Vaccines"},{"issue":"45","key":"17532_CR72","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1016\/j.vaccine.2021.09.074","volume":"39","author":"KE Corcoran","year":"2021","unstructured":"Corcoran KE, Scheitle CP, DiGregorio BD. Christian nationalism and COVID-19 vaccine hesitancy and uptake. Vaccine. 2021;39(45):6614\u201321.","journal-title":"Vaccine"},{"issue":"1","key":"17532_CR73","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1186\/s12889-021-11071-6","volume":"21","author":"S Syed Alwi","year":"2021","unstructured":"Syed Alwi S, Rafidah E, Zurraini A, Juslina O, Brohi IB, Lukas S. A survey on COVID-19 vaccine acceptance and concern among Malaysians. BMC Public Health. 2021;21(1):1129.","journal-title":"BMC Public Health"},{"issue":"5","key":"17532_CR74","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/vaccines9050446","volume":"9","author":"E Qunaibi","year":"2021","unstructured":"Qunaibi E, Basheti I, Soudy M, Sultan I. Hesitancy of Arab healthcare workers towards COVID-19 vaccination: a large-scale multinational study. Vaccines. 2021;9(5):446.","journal-title":"Vaccines"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-17532-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-023-17532-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-17532-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T06:01:39Z","timestamp":1704607299000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-023-17532-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,6]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["17532"],"URL":"https:\/\/doi.org\/10.1186\/s12889-023-17532-4","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,6]]},"assertion":[{"value":"21 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The study protocol was approved by the Mbarara University of Science and Technology Research Ethics Committee (number: MUST-2022-567). Administrative clearance was obtained from the City clerk (CR\/MC\/331) and the general managers to conduct research in the respective community pharmacies. Informed written consent was obtained from all eligible participants prior to recruitment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}